Regenxbio Inc.
Company Name: Regenxbio Inc. Regenxbio Inc. is a biotech company engaged in developing and licensing recombinant adeno-associated virus (AAV) gene therapy. Using its NAV Technology Platform, the company develops in vivo gene therapy products designed to treat various diseases, including homozygous familial hypercholesterolemia (HoFH), Mucopolysaccharidosis Type I (MPS I) and wet age-related macular degeneration (wet … Read more